MedPath

Metoprolol Tartrate

METOPROLOL TARTRATE INJECTION, USP

Approved
Approval ID

b624095a-d1c1-1ce0-e053-2995a90a0698

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 4, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metoprolol Tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7225
Application NumberANDA077761
Product Classification
M
Marketing Category
C73584
G
Generic Name
Metoprolol Tartrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 4, 2023
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEInactive
Quantity: 45 mg in 5 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
METOPROLOL TARTRATEActive
Quantity: 5 mg in 5 mL
Code: W5S57Y3A5L
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Metoprolol Tartrate - FDA Drug Approval Details